Detalhe da pesquisa
1.
Obesity and Risk for Lymphoma: Possible Role of Leptin.
Int J Mol Sci
; 23(24)2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555171
2.
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Front Immunol
; 15: 1293931, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469299
3.
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022).
Clin Transl Oncol
; 25(9): 2749-2758, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289353
4.
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
Front Immunol
; 14: 1266659, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38035104
5.
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.
Cancers (Basel)
; 14(6)2022 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326620
6.
Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases.
Front Immunol
; 13: 860891, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35493500
7.
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Clin Cancer Res
; 28(17): 3658-3668, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727601
8.
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
Sci Rep
; 11(1): 14426, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257359
9.
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial.
Cancers (Basel)
; 13(18)2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572849
10.
Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.
Viral Immunol
; 34(9): 639-645, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529510
11.
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study.
Cancers (Basel)
; 13(21)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771596
12.
Role of Isolated Limb Perfusion in the Era of Targeted Therapies and Immunotherapy in Melanoma. A Systematic Review of The Literature.
Cancers (Basel)
; 13(21)2021 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771649
13.
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158317
14.
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy.
Transl Cancer Res
; 8(1): 59-65, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35116734
15.
Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
Sci Rep
; 11(1): 17639, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462490